Your browser doesn't support javascript.
loading
Safety, efficacy and pharmacokinetics of low-dose telitacicept in an elderly immunocompromised patient with systemic lupus erythematosus.
Guan, Xin; Zhao, Zerui; Xia, Guangtao; Xin, Miaomiao; Yang, Qingrui; Sun, Hongling; Fu, Min.
Afiliação
  • Guan X; Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
  • Zhao Z; Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.
  • Xia G; Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
  • Xin M; Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
  • Yang Q; Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
  • Sun H; Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
  • Fu M; Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital), Jinan, China.
Int J Rheum Dis ; 26(7): 1399-1402, 2023 07.
Article em En | MEDLINE | ID: mdl-36807504
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article